---
title: "ARTHQ.US (ARTHQ.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ARTHQ.US/news.md"
symbol: "ARTHQ.US"
name: "ARTHQ.US"
parent: "https://longbridge.com/en/quote/ARTHQ.US.md"
datetime: "2026-03-05T17:48:59.828Z"
locales:
  - [en](https://longbridge.com/en/quote/ARTHQ.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ARTHQ.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ARTHQ.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ARTHQ.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ARTHQ.US/news.md)


# ARTHQ.US (ARTHQ.US) — Related News

### [Arthrex Releases TightRope® SB All-Suture Implant for ACL Fixation](https://longbridge.com/en/news/277081966.md)
*2026-02-26T18:10:44.000Z*
> Arthrex has launched the TightRope® SB implant, the first all-suture device for ACL reconstruction, enhancing minimally 

### [Arthex Biotech's ATX-01 promising for DM1 per American Journal of Human Genetics; miR-23b target shows benefits.](https://longbridge.com/en/news/276854985.md)
*2026-02-25T08:03:29.000Z*
> New findings suggest that miR-23b could be a crucial target in treating DM1, with research revealing its disease-modifyi